RLB Holdings and Kineta Announce Second Investment, and Partnership Focused on Program Advancement
SEATTLE--(BUSINESS WIRE)--RLB Holdings and Kineta are pleased to announce a new investment partnership focused on accelerating development of Kineta’s clinical stage drug candidates. The two drug programs funded by the investment partnership are ShK-186, a novel immune-sparing targeted therapeutic focused [...]